|
|
Volumn 26, Issue 6 SUPPL., 2006, Pages
|
|
Future treatment for retinal diseases: Where we will be
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGENTS ACTING ON THE EYE;
ANECORTAVE;
ANTIOXIDANT;
BEVACIZUMAB;
DEXAMETHASONE;
PEGAPTANIB;
POSURDEX;
RANIBIZUMAB;
SQUALAMINE;
TRIAMCINOLONE ACETONIDE;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONJUNCTIVA DISEASE;
DRUG DELIVERY SYSTEM;
DRUG IMPLANT;
GLAUCOMA;
HUMAN;
LIFESTYLE;
MEDICAL PROFESSION;
PREVALENCE;
RESOURCE ALLOCATION;
RETINA DISEASE;
RETINA MACULA AGE RELATED DEGENERATION;
RETINA VEIN OCCLUSION;
RETINITIS PIGMENTOSA;
RISK FACTOR;
SURGICAL TECHNIQUE;
TRANSPLANTATION;
TRANSPUPILLARY THERMOTHERAPY;
TREATMENT INDICATION;
UNSPECIFIED SIDE EFFECT;
VITRECTOMY;
VITREORETINOPATHY;
OPHTHALMOLOGY;
REVIEW;
HUMANS;
OPHTHALMOLOGY;
RETINAL DISEASES;
|
|
EID: 33747158830
PISSN: 0275004X
EISSN: None
Source Type: Journal
DOI: 10.1097/01.iae.0000236459.85522.df Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (1)
|
